Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 5Completed 3Terminated 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Resectable Lung Non-Small Cell Carcinoma 1Nasopharyngeal Carcinoma 1Immunotherapy Esophagus Cancer 1Hepatic Artery Infusion 1Advanced Solid Tumor 1

Interventions

Cisplatin 27Gemcitabine 22toripalimab 19Radiotherapy, Intensity-Modulated 18Capecitabine 10Radiotherapy 8Magnetic Resonance Spectroscopy 8nimotuzumab 7camrelizumab 7Specimen Handling 7Immune Checkpoint Inhibitors 7spartalizumab 5Drug Therapy 5Docetaxel 5Nivolumab 4Biopsy 4sintilimab 3Surgical Procedures, Operative 3Radiosurgery 3Platinum 3Fluorouracil 3Endoscopy 3Blood Specimen Collection 31,2-diaminocyclohexaneplatinum II citrate 3tislelizumab 2pembrolizumab 2irinotecan sucrosofate 2envafolimab 2apatinib 2anlotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Nasopharyngeal Carcinoma × nedaplatin × Clear all
NCT04437329 2022-05-10

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Recruiting
352 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡